PD-L1 expression on tumor cells, for example, has been correlated with enhanced responses to anti-PD-1/PD-L1 therapies, although its predictive accuracy remains limited due to modest sensitivity and specificity [52,53]. The gene discussed is CD274; the disease is neoplasm.